Citigroup
IQMD

Citigroup’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Citigroup’s Portfolio IQMD Stock Details IQMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,001
Closed -$504K – 6091
2022
Q3 		$504K Hold
50,001
– – ﹤0.01% 3229
2022
Q2 		$501K Hold
50,001
– – ﹤0.01% 3224
2022
Q1 		$500K Buy
+50,001
New +$497K ﹤0.01% 3503

Other funds holding IQMD

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Citigroup's IQMD Position: Q4 2022 in Review

Citigroup sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q4 2022, closing a stake of 50,001 shares — an estimated $504K sold.

Citigroup first reported a position in IQMD in Q1 2022 and held it in 3 quarters. The position peaked at $504K in Q3 2022. 60 funds tracked by Wall St. Rank hold IQMD as of Q4 2022.

  • Citigroup reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 50,001 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $504K.
  • Citigroup first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Citigroup's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $504K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.